3-hydroxy-5-cholestenoic acid has been researched along with cholanic acid in 1 studies
| Studies (3-hydroxy-5-cholestenoic acid) | Trials (3-hydroxy-5-cholestenoic acid) | Recent Studies (post-2010) (3-hydroxy-5-cholestenoic acid) | Studies (cholanic acid) | Trials (cholanic acid) | Recent Studies (post-2010) (cholanic acid) |
|---|---|---|---|---|---|
| 20 | 0 | 3 | 197 | 0 | 64 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akula, R; Ba, S; Ceballos-Diaz, C; Felsenstein, KM; Golde, TE; Hochhaus, G; Jung, JI; Koo, EH; Ladd, TB; Park, HJ; Price, AR; Ran, Y; Shapiro, G; Smithson, LA; Tang, Y | 1 |
1 other study(ies) available for 3-hydroxy-5-cholestenoic acid and cholanic acid
| Article | Year |
|---|---|
Cholestenoic acid, an endogenous cholesterol metabolite, is a potent γ-secretase modulator.
Topics: Amyloid beta-Peptides; Amyloid Precursor Protein Secretases; Animals; Blood-Brain Barrier; Brain; Cells, Cultured; CHO Cells; Cholestanetriol 26-Monooxygenase; Cholesterol; Cholic Acids; Coculture Techniques; Cricetinae; Cricetulus; Cytochrome P450 Family 7; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Humans; Mice; Mice, Inbred C57BL; Mice, Knockout; Molecular Structure; Neuroglia; Neurons; Peptide Fragments; Steroid Hydroxylases; Structure-Activity Relationship | 2015 |